Variant report
Variant | esv3389685 |
---|---|
Chromosome Location | chr6:114065159-114066207 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561729282 | chr6:114065211-114065212 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs576738574 | chr6:114065221-114065222 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs534607593 | chr6:114065244-114065245 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552958980 | chr6:114065252-114065253 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574334754 | chr6:114065267-114065268 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs541773691 | chr6:114065303-114065304 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs146641179 | chr6:114065316-114065317 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs575363324 | chr6:114065361-114065362 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546427805 | chr6:114065374-114065375 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2498753 | chr6:114065397-114065398 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs35174405 | chr6:114065413-114065414 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs143765170 | chr6:114065447-114065448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs71731976 | chr6:114065448-114065449 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs386408307 | chr6:114065450-114065451 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs71025067 | chr6:114065453-114065454 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs368002627 | chr6:114065454-114065455 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs371581304 | chr6:114065456-114065457 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2463309 | chr6:114065491-114065492 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189645870 | chr6:114065531-114065532 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs562147572 | chr6:114065551-114065552 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs371115973 | chr6:114065556-114065557 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs9488255 | chr6:114065558-114065559 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs533244023 | chr6:114065635-114065636 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529288407 | chr6:114065645-114065646 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs11968548 | chr6:114065665-114065666 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs183373921 | chr6:114065675-114065676 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs569014862 | chr6:114065696-114065697 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2498754 | chr6:114065733-114065734 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs551996668 | chr6:114065767-114065768 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570288193 | chr6:114065775-114065776 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs79719409 | chr6:114065787-114065788 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553007029 | chr6:114065833-114065834 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs149364875 | chr6:114065860-114065861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs187737489 | chr6:114065862-114065863 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs556955303 | chr6:114065866-114065867 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372282803 | chr6:114065912-114065913 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs575451772 | chr6:114065956-114065957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs144798632 | chr6:114065957-114065958 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs148551517 | chr6:114065995-114065996 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374914059 | chr6:114066000-114066001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs111854573 | chr6:114066012-114066013 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs527639151 | chr6:114066090-114066091 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs142027601 | chr6:114066091-114066092 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs540788235 | chr6:114066104-114066105 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs562268108 | chr6:114066147-114066148 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs540112291 | chr6:114066151-114066152 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs146147356 | chr6:114066157-114066158 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544211066 | chr6:114066177-114066178 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562535956 | chr6:114066191-114066192 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552121551 | chr6:114066199-114066200 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 21364760 | CNVD |
Chordoma | 21602918 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Systemic lupus erythematosus | 19220326 | CNVD |
Cancer | 17160897 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Acute lymphoblastic leukemia | 17229543 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Mental retardation | 17621639 | CNVD |
Hypoplastic | 20877625 | CNVD |
Hypotonia | 20877625 | CNVD |
Mental retardation | 20877625 | CNVD |
Microcephaly | 20877625 | CNVD |
brachycephaly | 20877625 | CNVD |
epicanthic folds | 20877625 | CNVD |
micrognathia | 20877625 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:114064000-114065800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr6:114064200-114066200 | Weak transcription | Fetal Heart | heart |
3 | chr6:114065000-114067800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr6:114065800-114066000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr6:114065800-114066400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
6 | chr6:114065800-114066400 | Enhancers | Fetal Lung | lung |
7 | chr6:114065800-114066400 | Enhancers | Fetal Muscle Leg | muscle |
8 | chr6:114065800-114066400 | Enhancers | Placenta | Placenta |
9 | chr6:114065800-114066400 | Enhancers | HepG2 | liver |
10 | chr6:114065800-114066800 | Enhancers | Adipose Nuclei | Adipose |
11 | chr6:114065800-114067200 | Enhancers | Psoas Muscle | Psoas |
12 | chr6:114065800-114067200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
13 | chr6:114066000-114066400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr6:114066000-114066600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr6:114066000-114066800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr6:114066000-114067000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
17 | chr6:114066000-114067200 | Enhancers | Colon Smooth Muscle | Colon |
18 | chr6:114066000-114067200 | Enhancers | Skeletal Muscle Male | skeletal muscle |
19 | chr6:114066200-114066400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
20 | chr6:114066200-114066600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
21 | chr6:114066200-114067200 | Enhancers | Fetal Heart | heart |